Invention Grant
- Patent Title: Medroxyprogesterone acetate injectable compositions and methods of use
-
Application No.: US17273392Application Date: 2019-09-06
-
Publication No.: US11752095B2Publication Date: 2023-09-12
- Inventor: Prakash Sundaramurthi , Ivana Mijakovac , Andrea Rasic , Iva Tunjic
- Applicant: Family Health International
- Applicant Address: US NC Durham
- Assignee: Family Health International
- Current Assignee: Family Health International
- Current Assignee Address: US NC Durham
- Agency: Parker Highlander PLLC
- International Application: PCT/IB2019/057537 2019.09.06
- International Announcement: WO2020/049521A 2020.03.12
- Date entered country: 2021-03-04
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/255 ; A61K31/566 ; A61K47/02 ; A61K47/10 ; A61K47/20
Abstract:
The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 260 mg/ml to 440 mg/ml medroxyprogesterone acetate, about 0.6 mg/ml to 1.5 mg/ml docusate sodium and, polyethylene glycol. Methods of using these compositions are also described.
Public/Granted literature
- US20220105027A1 MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE Public/Granted day:2022-04-07
Information query
